Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for osteoarthritis symptom improvement and molecular biomarker evaluation
IRCT20150202020908N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of metformin in osteoarthritis (OA) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Reducing pain, Weight loss and 2 more. Started Jun 2019; status: completed.
02
Drugs
metformin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20150202020908N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150202020908N2.